IRMD · Iradimed Corp
$94.26
-0.57 (-0.60%)
At close · Jul 29
Market Cap
$1.21B
Shares
12.78M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Roger Susi | CEO | $780,598 |
| John Glenn | CFO | $609,994 |
| Jeffrey Chiprin | Chief Commercial Officer | $529,360 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John Glenn | CFO | $1,262,892 |
| Roger Susi | CEO | $689,580 |
| Jeffrey Chiprin | Chief Commercial Officer | $388,683 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chris Scott | CFO | $1,155,632 |
| Roger Susi | CEO | $615,271 |
| MaryBeth Smith | Vice President of Sales | $36,268 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Leslie McDonnell | CEO | $624,157 |
| Chris Scott | CFO | $615,668 |
| MaryBeth Smith | Vice President of Sales | $517,774 |
| Roger Susi | CEO | $434,897 |
| Brent Johnson | Executive VP of Worldwide Sales and Marketing | $86,051 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Leslie McDonnell | CEO | $3,780,830 |
| Chris Scott | CFO | $587,753 |
| Roger Susi | CEO | $488,455 |
| Brent Johnson | Executive VP of Worldwide Sales and Marketing | $389,592 |
| MaryBeth Smith | Vice President of Sales | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Chris Scott | CFO | $508,451 |
| Roger Susi | CTO | $494,580 |
| Brent Johnson | Executive VP of Worldwide Sales and Marketing | $453,910 |
Key facts
CIK
1325618
CUSIP
46266A109
13F (30d)
58 filings
40 filers
Visit website
Investor relations